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a  b  s  t  r  a  c  t
The  present  study  is  aimed  to  enhance  the oral  bioavailability  of  ketoprofen  by  inserting  it into  the  matrix
of poly(vinylpyrrolidone)  (PVP)  K10  spatially  conﬁned  into  microcontainers,  by means  of supercritical
CO2-aided  impregnation.  Microcontainers  are  cylindrical  reservoirs,  with  typical  sizes  in  the  micrometer
range,  with  a  cavity  open  on  one  side,  where  the  drug  formulation  is  loaded.  Differently  to  traditional
tablets,  microcontainers  have  a higher  surface  area  per unit  volume,  and  release  the  drug  only  in one
direction.  This  design  is  meant  to enhance  the absorption  of problematic  drugs,  like those  with  poor  sol-
ubility in  water.  In a previous  study  we introduced  a  novel  technique  for  drug  loading  of  microcontainers,
based  on inkjet  printing  and  supercritical  impregnation  (SCI).  We  showed  that  SCI  produces  accurate  and
reproducible  drug  loading  for large  arrays  of  microcontainers.  In  the  attempt  of enhancing  the throughput
of  the  loading  methods,  we  propose  the  replacement  of  polymer  inkjet  printing  with  an  easier  man-
ual  compression  of  the  PVP  powder  into  the  microcontainers.  As the  second  step,  the  polymer  powder
ﬁlled-microcontainers  were  submitted  to  SCI.  The  separate  role  of different  impregnation  parameters
(temperature,  pressure,  time,  drug  concentration  in  the  supercritical  phase)  was elucidated  with  respect
to the loading  capacity.  The  microcontainer  ﬁlling  was  observed  by means  of optical  macroimaging,  X-
ray  microtomography  and  scanning  electron  microscopy.  The  physical  state  of  the  drug  was  investigated
by  means  of Raman  spectroscopy  and compared  with  selected  representative  PVP-ketoprofen  physical
mixtures.  Finally,  the  drug  loading  was  estimated  by means  of  in  vitro  dissolution  tests.
The  characterization  study  shows  that  the  present  loading  method  is  a valuable  alternative  to the one
previously  described.  The  drug  loading  can  be controlled  with  high  accuracy  and  reproducibility  and
the impregnated  drug  is  in amorphous  state. These  results  demonstrate  that  SCI  can  be  used  as  a high
throughput  loading  technique  for  microfabricated  devices  for oral  drug  delivery.
©  2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license. Introduction
Among the different drug delivery routes oral administration
s still the most preferred one for its simplicity, minimal inva-
iveness, and high patient compliance. Nevertheless, the human
igestive system presents a sequence of physiological barriers
hich drastically reduce the bioavailability of many active phar-
aceutical ingredients (API): enzymatic degradation, hydrolysis
∗ Corresponding author.
E-mail address: paom@nanotech.dtu.dk (P. Marizza).
ttp://dx.doi.org/10.1016/j.supﬂu.2015.08.023
896-8446/© 2015 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
in the gastric acidic environment, thick mucus layer covering the
intestinal mucosa, selective transport action of peptide receptors
in the epithelial cells [1]. In particular, oral delivery of APIs that
exhibit either low solubility in water or low permeability through
biological membranes or both is challenging. The solid state prop-
erties of drugs have a strong inﬂuence on their solubility. Whilst
amorphous drug candidates exhibit an enhanced solubility and
dissolution rate compared to their crystalline counterparts, amor-
phous forms often suffer from rather short thermodynamic stability
and they spontaneously tend to crystallize [2]. As a result, sta-
bilization of amorphous forms is necessary in order to preserve
the above-mentioned advantages [3]. Physical stabilization of the
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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morphous form can be achieved by the addition of a polymeric
arrier wherein the drug is conﬁned in supramolecular domains
r even molecularly dispersed [4]. Together with the solid state
roperties, the solubility and dissolution rate can be improved by
educing the particle size of the formulation [5]. Among the several
ormulation approaches [6] supercritical ﬂuid based technology
s a promising technique to produce micro- and nanoparticulate
ystems with high drug dispersion and enhanced stability and dis-
olution properties [7].
Besides the properties of the drug formulation, an important role
n the therapeutic performance is often played by the design of the
dministration form. Conventional oral dosage forms like tablets
rovide an omni-directional drug release through their limited
nterfacial area when exposed to the physiological ﬂuids. Further-
ore, drug release from tablets is often slow compared to the
eristaltic ﬂow in the small intestine, where the most permeable
issue for drug absorption is located. As a result, a large amount
f API is not delivered, and patients need to ingest multiple drug
oses to receive the desired therapeutic beneﬁt. This increases the
ccurrence of potentially harmful side effects in patients [8].
In the last 10 years advances in ﬁeld of micro- and nanofabri-
ation have allowed the development of alternative drug delivery
ystems [9]. In particular there has been an increasing interest in
icrofabricated devices based on the concept of microcontainers
10]. A microcontainer is a reservoir with the typical dimensions
alling in the micrometer range, composed of a non-permeable
nd inert shell and a cavity for the drug formulation open on one
ide from which the drug is released unidirectionally. The size
f these microcontainers are chosen to allow an enhanced inti-
ate contact with the irregular surface of the mucosa with respect
o other macroscopic drug delivery systems and to avoid typical
ssues of smaller micro- and nano-sized systems like clustering,
hysical stability and unspeciﬁc endocytosis. Several groups devel-
ped microcontainers in different shapes, materials and designs,
here fabrication is typically performed on ﬂat silicon substrates.
y virtue of its asymmetric shape and by applying appropri-
te bioadhesive coatings on microcontainers Ainslie et al. [11]
howed an increased intestinal retention time for these microde-
ices and an enhanced bioavailability for a model poorly water
oluble drug. One of the largest challenges in the fabrication of
icrocontainers concerns the drug loading step. In a previous work
12], we showed the fabrication of cylindrical microcontainers,
abricated with the epoxy resin SU-8. The microwells were ﬁlled
ith poly(vinylpyrrolidone) (PVP) by inkjet printing. This method
howed high accuracy and a minimal waste of materials. In a more
ecent work [13] we proposed the combination of inkjet prin-
ing and supercritical technology to impregnate the polymer-ﬁlled
icrocontainers with ketoprofen, a poorly water soluble drug. We
emonstrated that the supercritical impregnation technique allows
 highly accurate and reproducible drug loading of large arrays of
icrocontainers. In an attempt to enhance the throughput of this
oading method, we propose a simpliﬁed variant of our previous
ork. Here the polymer printing was replaced by an easier ﬁlling
ethod, consisting of a manual compression of the polymer pow-
er into the microcontainer. Later, the powder ﬁlled-containers
ere submitted to supercritical impregnation (SCI) as previously
escribed [13]. This process modiﬁcation enabled a signiﬁcant
eduction in the sample preparation time and made it possible to
nvestigate the effect of temperature, pressure and impregnation
imes on different aspects concerning the drug loading in more
etail.
The loading procedure was characterized with different tech-
iques. X-ray microtomography was used to measure the level
f ﬁlling and the morphology of the polymer powder in the
icroreservoir cavities before and after the SCI. In addition, micro-
ontainers were visualized by scanning electron microscopy (SEM)Fig. 1. Chemical structure of (a) ketoprofen, (b) monomer of poly(vinyl pyrrolidone)
(PVP).
to observe the effect of the impregnation parameters on the poly-
mer  morphology. Raman spectroscopy was used to investigate the
drug solid state in the impregnated matrices and drug-polymer
interactions. Finally, in vitro dissolution tests were carried out and
the total drug loading was estimated. The results showed that
the replacement of inkjet printing with the powder ﬁlling method
enhances the throughput of the microcontainer loading technique
without compromising the accuracy or the reproducibility of the
whole loading process.
2. Materials and methods
2.1. Fabrication of SU-8 microcontainers
2.1.1. Materials and fabrication of microcontainers
Silicon wafers (4-in. b100N n-type) were supplied by Okmetic
(Vantaa, Finland). SU-8 2075 and SU-8 developer were purchased
from Microresist Technology GmbH (Berlin, Germany).
Cylindrical microcontainers were fabricated with a similar
procedure as previously described [12]. The microwells were fab-
ricated with the epoxy-based photoresist SU-8 on silicon wafers. A
microcontainer has a cavity of approximately 300 m in diameter
and 250 m in depth and an approximated volume of 18 nL. After
the fabrication the wafer was  cut into square chips containing 625
microcontainers (DISCO DAD 321, Automatic Dicing Saw).
2.2. Drug loading of microcontainers
2.2.1. Materials
Ketoprofen (98%, racemate) and poly(vinylpyrrolidone) (PVP
K10, Mw 10,000) were supplied by Sigma Aldrich. In Fig. 1 the
molecular structures of the compounds are shown. Carbon diox-
ide was supplied by SIAD (99% purity). Ketoprofen is a nonsteroidal
anti-inﬂammatory drug (NSAID) with analgesic and antipyretic
properties. In several pharmacopeias ketoprofen is considered as
practically insoluble in water [14,15]. The solubility of the crys-
talline form of ketoprofen in pure water at room temperature
(22–24 ◦C) was  reported to be 0.010 mg/mL [15]. Thus, ketoprofen
is classiﬁed as a class II active principle in the biopharmaceutical
classiﬁcation system (BCS): It exhibits low aqueous solubility and
a high intestinal permeability.
2.2.2. Filling with poly(vinylpyrrolidone) PVP powder
Microcontainers were ﬁlled with PVP powder with the following
procedure: The powder was  deposited and compacted with a spat-
ula onto the microwells and the residual amount, placed in between
containers, was  blown away by means of pressurized air. The chip
was weighed before and after ﬁlling and the average PVP weight per
chip was 1.93 ± 0.08 mg  (calculated from 35 samples). The level of
microcontainer ﬁlling was  measured by X-ray microtomography at
different positions on the chip.2.2.3. Supercritical impregnation of polymer
ﬁlled-microcontainers
After the powder deposition the drug was loaded into the
polymer-ﬁlled microdevices by means of supercritical carbon
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 Fi and Vi indicate 0.5 m ﬁlters and on/off valves.
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Table 1
Weighted mass of ketoprofen [mg] dissolved at different experimental conditions.
Pressure [bar] Temperature [◦C]
40 50 60Fig. 2. Schematic of the high pressure plant.
ioxide impregnation. Fig. 2 depicts a schematic of the high pres-
ure setup used in the impregnation experiments. The operation
as performed in a 100 mL  reactor (KM 20-05 autoclave NWA,
ermany) equipped with a magnetic stirrer drive (Mrk MINI 100)
ssembled in a sealed housing directly threading into the reactor
ead. During the impregnation experiments the reactor was fed
ith liquid CO2 through an on/off valve (V1) by a high pressure
ump (PM-101NWA, NWA, Germany). At the end of the exper-
ments the reactor was slowly emptied through an on/off purge
alve followed by a lamination valve (V2) and the outlet stream
as connected to a deﬂux ﬂask were the gaseous CO2 was  bub-
led through an ethanol solution (95%). Finally, the drug free-CO2
tream was connected to a ﬂowmeter (SIM Brunt, Italy).
The impregnation experiments were carried out in batch condi-
ions with deﬁned steady-state values of CO2 pressure, temperature
nd stirring velocity. In each experiment, weighted amounts of
rystalline ketoprofen powder and one chip were placed in sep-
rate compartments of a sample carrier placed at the bottom of
he reactor. In order to avoid damage to the microcontainers dur-
ng the chamber ﬁlling with the supercritical ﬂuid, the back of the
hips were glued onto the sample carrier with a carbon tape pad.
he reactor was then sealed and heated to the deﬁned tempera-
ure. When the set point temperature was achieved, the inlet valve
as gradually opened and the chamber was slowly ﬁlled with CO2,
n order to maintain isothermal conditions and avoid turbulence
ithin the reactor, which could result in detachment of the chip and
amaging of the microcontainers. When the desired pressure was
chieved, the inlet valve was closed and the stirrer was  switched
n. During the experiment the supercritical CO2 phase dissolved
he solid drug powder and swelled the polymer within the micro-
ontainers. The drug was therefore physically conveyed and loaded
n the polymer matrices. The impregnations were carried out at a
uid pressure of 100 and 200 bar, temperatures of 40, 50 and 60 ◦C
nd durations of 1 and 4 h with a stirring velocity of 20 rpm.
In the experiments run at 100 bar the amount of drug placed
n the chamber was selected to initially achieve complete disso-
ution in supercritical CO2 and saturation conditions according to
he solubility values of ketoprofen reported by Macnaughton et al.
16] at the chosen temperature. In this group of experiments the
emperature and time were modiﬁed from batch to batch. Because
f the batch conditions, the drug concentration could not be kept
t saturation value over time. In contrast, in the tests performed
t 200 bar a ﬁxed amount of ketoprofen was weighted and dis-
olved, based on the amount to reach saturation concentration for
he compound at 200 bar and 40 ◦C. As a consequence, at 200 bar
nd 50 ◦C and 60 ◦C operation will be below saturation conditions,
s the solubility values are higher at these temperatures. In the
xperiment performed at 200 bar, the exclusive effect of temper-
ture and time on the microcontainer impregnation was studied.
t the end of the experiment the reactor was depressurized at a
ontrolled rate for approximately 2 and 3 h when the operating
ressures were 100 and 200 bar respectively. After the experiments
he chips were stored in a desiccator until further analysis were100 4.83 2.15 1.31
200  14.1 14.1 14.1
performed. In Table 1 the operating conditions of the experiments
are shown.
2.3. Characterization methods
2.3.1. X-ray microtomography (XCT)
For the XCT measurements a Skyscan 1172/F instrument
(Skyscan, Kontich, Belgium, control software v1.5.13) was used. A
source voltage of 60 kV and current of 165 A were used together
with a 0.5 mm thick Al ﬁlter to attenuate the high energy X-rays. For
each sample 780 shadow images were acquired over 180◦ of rota-
tion. The resulting data acquisition time was  4 h for each sample.
Reconstruction of the cross-section images was performed using
the program NRecon + GPUReconServer (Skyscan, beta v1.6.5) on a
single PC using GPU accelerated reconstruction (Windows 7 64-bit
workstation, 2 Intel Xeon X5647 with 4 cores each, 48 GB RAM,
NVIDIA quadro 4000 with 256 cores). Image reconstruction using
the Feldkamp algorithm [17] for cone beam geometry took about
30 min  per sample and resulted in, depending on sample size, about
1450 slices of 2864 × 2876 pixels each (5.2 m isotropic voxel size).
Using the DataViewer (Skycan, v1.4.4) the tablet was rotated to
align the microwells parallel to the x-axis.
2.3.2. Scanning electron microscopy (SEM)
The morphology of the impregnated microcontainers was
examined using SEM. The investigations were carried out using a
Nova600 NanoSEM from FEI (Eindhoven, the Netherlands). Imag-
ing was  performed in low-vacuum-mode at a pressure of 0.6 mbar
and an operation voltage of 5 kV. Prior to examination, the samples
were mounted onto metal stubs and were tilted by approx. 30◦.
2.3.3. Raman spectroscopy
As described in a previous study [13], Raman spectroscopy can
be used to elucidate the presence of chemical interactions amongst
drug molecules and between drug and polymer. The spectra from
the impregnated microcontainers were collected using a Thermo
Scientiﬁc Raman DXR microscope equipped with a frequency-
stabilized single mode diode laser. The Raman signal collection time
was 5 s and the signal was  averaged three times, using a 25 m slit
and a 1.0 m diameter laser post. The Raman DXR microscope was
coupled to a single grating spectrometer with a 5 cm−1 FWHM (full
width half maximum) spectral resolution and a ±2 cm−1 wavenum-
ber accuracy. All Raman spectra were recorded at a laser power of
10 mW,  using a 10× objective lens and a laser excitation wave-
length of 780 nm.  In each sample 5 containers, located at different
148 P. Marizza et al. / J. of Supercritical Fluids 107 (2016) 145–152
anual compaction: (a) detail of the chip corner, (b) arrays in the middle of the chip.
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FFig. 3. Optical macro images of microcontainers ﬁlled with PVP powder by m
ositions on the chip, were selected and analyzed. The intrinsic
uorescence background was ﬁtted to a polynomial function and
ubtracted from the collected signal.
.3.4. In vitro drug dissolution studies
The loading of ketoprofen was determined by in vitro dissolu-
ion tests of impregnated microcontainers in 10 mL  DI water at
7 ◦C using a UV spectrophotometer DISS proﬁler (Pion, USA).
ndividual chips were glued with carbon pads on teﬂon-coated
agnets which stirred at 100 rpm. For the detection of ketoprofen,
he wavelength was set to 259 nm.  After dissolution, the microcon-
ainers were observed with an optical microscope (Zeiss, Germany,
0× magnitude) to conﬁrm complete emptying. The amount of
rug loaded per chip was estimated by the ﬁnal concentration
easured in the dissolution test at 16 h. Solubility of ketopro-
en at 37 ◦C in aqueous solutions changes signiﬁcantly with pH
etween 1 and 7 [14]. However, even in the test with the high-
st drug loading, the pH of the dissolution medium drop below
.5 as ketoprofen is a weak acid (pKa 4.5). Therefore, according to
olubility data reported in the literature [14], the dissolution tests
ere performed in conditions below saturation that is without drug
recipitation, which was also conﬁrmed by the non-decreasing
onotonic trend of the drug dissolution proﬁles (data not
hown).
. Results and discussion
.1. Polymer ﬁlling of microcontainers and X-ray
icrotomography
A picture of arrays of microcontainers ﬁlled with PVP powder is
hown in Fig. 3. The powder ﬁlling required few seconds to be per-
ormed and resulted in an accurate deposition inside the cylindrical
avities of the microwells, with minimal residues in between, as
epresentatively illustrated by the high color contrast between the
ark silicon surface and the brilliant white of PVP powder. In Fig. 4
 scanning electron microscopy image of microcontainers ﬁlled
ith PVP powder is reported. The polymer granules are compacted
nside the microwells and this conﬁnement prevents them from
eing removed by the air ﬂow which is used to remove the loose
owder in between containers after the ﬁlling step. Fig. 5 shows the
ross-sections that were reconstructed from the microtomography
ata of the XCT measurements. Using this technique it is possible
o measure the internal microstructure of the PVP powder within
he containers and to visualize the effect of the impregnation on the
article morphology. The images clearly show that the microcon-
ainers are ﬁlled with discrete PVP particles which subsequently
oalesce in bigger clusters following supercritical impregnation
ith ketoprofen at 200 bar, 40 ◦C and 1 h for the example in
ig. 5.Fig. 4. SEM images of microcontainers ﬁlled with poly(vinylpyrrolidone) before
treatment with supercritical CO2. The scalebar indicates 300 m.
3.2. Scanning electron microscopy of impregnated
microcontainers
After the supercritical treatment, the microcontainers were ana-
lyzed by scanning electron microscopy to observe the effects of the
impregnation on the polymer morphology. As shown previously
[13], the SEM micrographs (see Fig. 6) conﬁrm that scCO2 does
not visible effects on the epoxy resin SU-8 used to fabricate the
microcontainers, which maintain their size, the cylindrical shape
and the adhesion to the silicon substrate. The supercritical ﬂuid
has instead a much more pronounced effect on PVP. At all the
tested conditions, the morphology of PVP radically changes as the
polymer particles undergo swelling and subsequent coalescence
as conﬁrmed by the XCT images (Fig. 5b). By comparing the SEM
micrographs of microcontainers treated at different pressures it is
clear that the volume of the polymer visibly increases with increas-
ing CO2 pressure. This might be also due to the presence of higher
drug amounts loaded in the polymer matrix. This can be explained
by an increase of CO2 uptake in PVP with pressure, in accordance
with what was  previously reported by Kikic and co-workers [18].
At high pressures, CO2 has a well-known plasticizing effect on cer-
tain polymers [19,20]. The plasticization leads to a drop of the Tg
from 120 to 128 ◦C for PVP [21] to a temperature close to the operat-
ing temperature during impregnation. As a result, the polymer gets
close to the glass-rubber transition. The increase of impregnation
time in general leads to a higher extent of swelling of the matrix
and to the appearance of holes. At 40 ◦C and 50 ◦C these holes got
larger when the pressure was  set at 200 bar, and this fact can be
attributed to the release of CO2 from the highly swollen matrices
upon depressurization. At 200 bar and 50 ◦C small spots appear on
P. Marizza et al. / J. of Supercritical Fluids 107 (2016) 145–152 149
F ners ﬁ
b n toge
t
i
t
v
t
i
3
w
i
p
s
t
i
s
a
d
s
F
tig. 5. Cross-sections non-destructively acquired by XCT through the microcontai
y  supercritical CO2 (200 bar, 40 ◦C, 1 h) (b). The original gray scale images are show
he polymer surface. At 200 bar and 60 ◦C these particles clustered
n larger aggregates (see Fig. 6k and l) on a small number of con-
ainers on the chip. As scCO2 acts as a plasticizer for polymers the
iscosity of the CO2 saturated matrix decreases during impregna-
ion in some cases causing spillages from the containers. This aspect
s more pronounced during longer experiments.
.3. Loading of ketoprofen into polymer ﬁlled-microcontainers
The solubility of ketoprofen in scCO2 monotonically increases
ith the ﬂuid density, and therefore with the ﬂuid pressure at
sothermal conditions [16]. Furthermore, for many active com-
ounds under isobaric conditions the temperature inﬂuences the
olubility according to the operating pressure and with respect
o the crossover pressures. At the crossover points solubility
sotherms overturn their trend [16]. The upper crossover pres-
ure of ketoprofen in carbon dioxide was measured between 160
nd 180 bar [18,22]. Below this pressure, such as at 100 bar, the
rug solubility decreases with temperature. At higher pressures,
uch as at 200 bar, the effect of temperature is the opposite. The
ig. 6. Scanning electron microscopy images of polymer ﬁlled microcontainers impregn
ime.  The scalebars indicate 300 m.lled with poly(vinylpyrrolidone) before (a) and after impregnation with ketoprofen
ther with a binary threshold image to highlight the change in polymer morphology.
impregnation pressures were chosen at a value below and above
the upper crossover point in order to explore the inﬂuence/effect
of the supercritical phase on the drug loading. In Fig. 7 the result-
ing weight fraction of ketoprofen (ωketo) respect to drug + polymer
mass, loaded in a chip containing 625 PVP ﬁlled-microcontainers is
compared for the different impregnation conditions. In Table 2 the
overall drug loading results are shown.
Despite the simplicity of the method the overall accuracy of the
loading is similar to the one previously reported where the polymer
was deposited by inkjet printing [12].
In the tests carried out at 100 bar (Fig. 7a) the drug was dissolved
in saturation conditions. Here the loading is strongly dependent on
the drug concentration in the supercritical phase, which was  higher
at 40 ◦C and lower at 60 ◦C. There is an increase in drug loading
over time for any tested temperature meaning that after 1 h the
equilibrium is not yet attained. After 4 h the drug weight fraction is
approximately doubled at all temperatures. To investigate the par-
tition equilibrium of the drug between the CO2 and the polymer
phases an impregnation experiment was  carried out at 100 bar and
40 ◦C for 24 h. The attained drug fraction was  0.27, which is very
ated with ketoprofen by supercritical CO2 at different pressure, temperature and
150 P. Marizza et al. / J. of Supercritical Fluids 107 (2016) 145–152
Fig. 7. Mass fraction of ketoprofen (ωketo) impregnated in polymer ﬁlled 625 microcontainers at different temperatures and times: (a) at 100 bar in saturation conditions (b)
at  200 bar with a ﬁxed amount of drug dissolved in scCO2 (N = 3).
Table 2
Drug loading of impregnated microcontainers. The drug weight refers to total loaded mass on individual chips (625 microcontainers) and is normalized with respect to the
polymer mass in the microwells (N = 3).
T (◦C) P (bar) Time (h) Loaded drug per chip (mg) Drug weight fraction (keto/(PVP + keto))
40
100
1 0.33 ± 0.09 0.15 ± 0.03
4  0.58 ± 0.02 0.26 ± 0.02
100  24 0.49 0.27
200
1  0.53 ± 0.07 0.23 ± 0.03
4  0.58 ± 0.01 0.27 ± 0.03
50
100
1  0.19 ± 0.02 0.10 ± 0.01
4  0.40 ± 0.04 0.18 ± 0.02
200
1  0.55 ± 0.03 0.26 ± 0.01
4  0.71 ± 0.04 0.27 ± 0.03
60
100
1  0.08 ± 0.03 0.04 ± 0.01
4  0.16 ±
200
1  0.77 ±
4  1.05 ±
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tig. 8. Mass of ketoprofen impregnated at 200 bar in 625 microcontainers at differ-
nt temperatures and times (N = 3) as function of the CO2 density.
lose to the loading achieved after 4 h. In the experiments at 200 bar,
he impregnation is enhanced compared to experiments at 100 bar
s a result of the combined effect of the higher amount of drug dis-
olved (see Table 1) and the density of the ﬂuid at this pressure.
owever, at 200 bar the loading increased with the temperature
hich was unexpected, since at this pressure a rise of temperature
eads to an increase of drug solubility and therefore a less favor-
ble drug partition in the polymer matrix. Moreover, from 40 ◦C to
0 ◦C the ﬂuid density decreases as shown in the proﬁles in Fig. 8,
here the loaded API weights are plotted as a function of the CO2
ensity. These latter results can be explained by considering that
he effect of temperature on drug-scCO2 diffusivity prevails over
he reduced ﬂuid density. A temperature increase also results in 0.04 0.06 ± 0.01
 0.06 0.26 ± 0.03
 0.03 0.33 ± 0.01
enhanced mobility of the polymer chains, which is suggested by the
visible swelling observed in Fig. 6d, h and l. In contrast to the results
at 100 bar, at 200 bar more limited loading gains were achieved
with increased impregnation time. This might be due to the prox-
imity of the drug concentration in the polymer to saturation, which
can slow down the impregnation process.
3.4. Raman spectroscopy
Another important aspect for a drug delivery device are the
API solid state properties and the stabilization of the amorphous
phase in a polymer matrix. For this purpose, Raman scattering
spectroscopy was  utilized to detect the presence of amorphous
ketoprofen and the molecular interactions with the polymer. The
supercritical impregnation of PVP ﬁlms with poorly soluble drugs
was previously investigated by vibrational spectroscopy [23–25]. In
order to elucidate the presence of drug-polymer interactions, addi-
tional Raman spectra were collected from microcontainers ﬁlled
with physical mixtures (PMs) of the polymer and drug. Physi-
cal mixtures were obtained by gentle mixing PVP and ketoprofen
powders and subsequent ﬁlling in microcontainers as previously
described [13]. Raman scattering spectra of both fresh ketopro-
fen:PVP PMs  and mixtures prepared by supercritical CO2 are shown
in Fig. 9. In the ketoprofen:PVP PM case, the Raman scattering
spectra from both compounds are added together and retain all
characteristics of isolated ketoprofen and PVP, see Fig. 9a. To
illustrate this, the inter-ring ketoprofen carbonyl [C O] stretch-
ing mode found at 1657 cm−1 is examined for different drug/PVP
ratios [26]. A previously reported by Carvalho et al. [27], a frequency
shift for this signal can be associated to the formation of H-bonds
involving the C O group between ketoprofen and PVP. In all cases
the Raman intensity of the ketoprofen C O stretching mode com-
pared to the 1602 cm−1 C–C stretching mode is I1657/I1602 > 1. The
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dig. 9. Raman spectra of (a) physical mixtures of PVP and crystalline ketoprofen in 
ame  ketoprofen weight percentages at different experimental conditions (see Tabl
aman vibration can be ﬁtted to two Lorentzian functions outlin-
ng modes that belong to both ketoprofen and PVP. The FWHM of
he C O stretching mode is similar to the one recorded for pure
etoprofen shown in the bottom part of Fig. 9a. The PM result
ndicates no observable intermolecular interaction between the
wo compounds [13]. The 1657 cm−1 Raman mode for supercriti-
al CO2 impregnated ketoprofen:PVP mixtures behaves differently,
.e. the vibrational mode intensity is reduced and the FWHM is sig-
iﬁcantly increased, see Fig. 9b. In this case, the two Lorentzian
ts yield essentially a single Raman peak without a clear contri-
ution from PVP and I1657/I1602 < 1 almost for all drug/PVP ratios.
ince there is no observable frequency shift, the result suggests that
his carbonyl group is not involved in the formation of hydrogen
onds with PVP molecules. The recorded change rather indicates
earrangement of ketoprofen molecules into a less organized amor-
hous solid state, and a similar effect was previously observed for
ged ketoprofen:PVP PM mixtures [13]. The presence of amorphous
etoprofen was previously conﬁrmed by X-ray diffraction [13]. It
s also expected that the CO2 assisted impregnation of PVP with
etoprofen breaks or reduces the interaction between adjacent
etoprofen molecules and induces the formation of the hydrogen
onds between hydroxyl groups of ketoprofen molecules and car-
onyl groups of PVP [24].
. Conclusions
The present study investigates the use of CO2-aided impreg-
ation to load ketoprofen into microcontainers ﬁlled with PVP
y tuning temperature, pressure, time, and drug concentration
n the ﬂuid phase. The characterization study shows that drug
oading can be controlled with high accuracy and reproducibil-
ty and the impregnated drug is in the amorphous state. At any
ested pressure there is an increase of drug loading over time for
ny tested temperature meaning that after 1 hour the equilibrium
etween the polymer and the CO2 phases is not yet attained. From
he tests at 100 bar it was observed that the loading is strongly
ependent on the drug concentration in the impregnating medium.nt representative weight percentages and (b) spectra of PVP impregnated with the
Unexpectedly, in the tests at 200 bar the loading increased with the
temperature despite the increasing drug solubility in the scCO2.
This was attributed to the predominant effect of drug diffusivity
in the polymer matrix. In contrast, at 200 bar more limited loading
gains for increasing impregnation time were obtained probably due
to drug saturation in the polymer. The Raman scattering spectra
of the impregnated matrices indicate a rearrangement of ketopro-
fen molecules into a less organized state. However, no observable
frequency shift in was  noticed for the spectral modes typically
ascribed to drug-polymer interactions, which suggests that the
drug molecule is unlikely to be involved in the formation of hydro-
gen bonds with PVP molecules.
Our results demonstrate that the combination of powder load-
ing and SCI can be used as a high throughput loading technique for
microfabricated devices for oral drug delivery.
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